Arbutus Biopharma

Description: 

Arbutus Biopharma Corporation (NASDAQ: ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). 

Location(s): 
Burnaby BC
Canada
Warminister PA
United States